A selective and potent non-peptide angiotensin II type 2 (AT2) receptor antagonist. Potential treatment of cardiac hypertrophy as blockage of AT2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Studies show that it has protective effect against tumor necrosis factor-alpha-induced damage to human renal proximal tubular epithelial cells Form: Pale Beige Solid Melting Point: 111-114C Solubility: Chloroform, Methanol Pfizer Compound
Molecular Weight:
736.66
Form:
Pale Beige Solid
* VAT and and shipping costs not included. Errors and price changes excepted
